Glucose-lowering drugs and outcome from COVID-19 among patients with type 2 diabetes mellitus: a population-wide analysis in Hong Kong
Open Access
Abstract
Objectives To investigate the association between baseline use of glucose-lowering drugs and serious clinical outcome among patients with type 2 diabetes. Design Territory-wide retrospective cohort of confirmed cases of COVID-19 between January 2020 and February 2021. Setting All public health facilities in Hong Kong. Participants 1220 patients with diabetes who were admitted for confirmed COVID-19. Primary and secondary outcome measures Composite clinical endpoint of intensive care unit admission, requirement of invasive mechanical ventilation and/or in-hospital death. Results In this cohort (median age 65.3 years, 54.3% men), 737 (60.4%) patients were treated with metformin, 385 (31.6%) with sulphonylureas, 199 (16.3%) with dipeptidyl peptidase-4 (DPP-4) inhibitors and 273 (22.4%) with insulin prior to admission. In multivariate Cox regression, use of metformin and DPP-4 inhibitors was associated with reduced incidence of the composite endpoint relative to non-use, with respective HRs of 0.51 (95% CI 0.34 to 0.77, p=0.001) and 0.46 (95% CI 0.29 to 0.71, pConclusions Users of metformin and DPP-4 inhibitors had fewer adverse outcomes from COVID-19 compared with non-users, whereas insulin and sulphonylurea might predict a worse prognosis.Keywords
Funding Information
- Health and Medical Research Fund (COVID1903002)
This publication has 41 references indexed in Scilit:
- Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studiesCritical Care, 2019
- Addressing Extreme Propensity Scores via the Overlap WeightsAmerican Journal of Epidemiology, 2018
- AMP-activated Protein Kinase Phosphorylation of Angiotensin-Converting Enzyme 2 in Endothelium Mitigates Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysisAlimentary Pharmacology & Therapeutics, 2017
- Anti-Inflammatory Effects of Metformin Irrespective of Diabetes StatusCirculation Research, 2016
- Metformin: From Mechanisms of Action to TherapiesCell Metabolism, 2014
- Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive studyThe Lancet Infectious Diseases, 2013
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMCNature, 2013
- Glyburide Is Anti-inflammatory and Associated with Reduced Mortality in MelioidosisClinical Infectious Diseases, 2011
- Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARSDiabetic Medicine, 2006